Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureMarian E. Melish
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Treatment and outcomes of Kawasaki disease over 40 years
10.1542/peds.2026-076338 · 2026
The treatment of Kawasaki syndrome with intravenous gamma globulin
10.1056/nejm198608073150601 · 1986
A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome
10.1056/nejm199106063242305 · 1991
Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients
10.1161/01.cir.94.6.1379 · 1996
Medium-term complications associated with coronary artery aneurysms after Kawasaki disease: a study from the International Kawasaki Disease Registry
10.1161/jaha.119.016440 · 2020
Analysis of coronary arterial aneurysm regression in patients with Kawasaki disease by aneurysm severity: factors associated with regression
10.1161/jaha.121.022417 · 2023
Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study
10.1371/journal.pone.0038998 · 2012
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial
10.1016/s2352-4642(21)00270-4 · 2021
Treatment intensification in patients with Kawasaki disease and coronary aneurysm at diagnosis
10.1542/peds.2018-3341 · 2019
Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial
10.1016/s0140-6736(11)61930-2 · 2012
Randomized trial of adjunctive prednisolone for Kawasaki disease
10.1056/nejmoa2511478 · 2026
No additional external references are available.